Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) Other Operating Expenses (2018 - 2025)

Viemed Healthcare's Other Operating Expenses history spans 8 years, with the latest figure at -$289000.0 for Q4 2025.

  • For Q4 2025, Other Operating Expenses fell 126.18% year-over-year to -$289000.0; the TTM value through Dec 2025 reached $2.2 million, up 17.53%, while the annual FY2025 figure was $2.2 million, 17.53% up from the prior year.
  • Other Operating Expenses reached -$289000.0 in Q4 2025 per VMD's latest filing, up from -$476000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $2.4 million in Q1 2025 to a low of -$476000.0 in Q3 2025.
  • Average Other Operating Expenses over 5 years is $135250.0, with a median of -$100000.0 recorded in 2021.
  • Peak YoY movement for Other Operating Expenses: plummeted 1068.18% in 2024, then skyrocketed 1211.74% in 2025.
  • A 5-year view of Other Operating Expenses shows it stood at -$144000.0 in 2021, then fell by 23.61% to -$178000.0 in 2022, then crashed by 52.81% to -$272000.0 in 2023, then skyrocketed by 505.88% to $1.1 million in 2024, then crashed by 126.18% to -$289000.0 in 2025.
  • Per Business Quant, the three most recent readings for VMD's Other Operating Expenses are -$289000.0 (Q4 2025), -$476000.0 (Q3 2025), and $636000.0 (Q2 2025).